BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34014604)

  • 21. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA.
    Baysal BE; Lawrence EC; Ferrell RE
    BMC Biol; 2007 Mar; 5():12. PubMed ID: 17376234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
    Bayley JP; Devilee P; Taschner PE
    BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
    Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
    Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recessive germline SDHA and SDHB mutations causing leukodystrophy and isolated mitochondrial complex II deficiency.
    Alston CL; Davison JE; Meloni F; van der Westhuizen FH; He L; Hornig-Do HT; Peet AC; Gissen P; Goffrini P; Ferrero I; Wassmer E; McFarland R; Taylor RW
    J Med Genet; 2012 Sep; 49(9):569-77. PubMed ID: 22972948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
    Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoexpression of SDHB, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study.
    Karatay H; Ozluk Y; Dogan MA; Erdem S; Kilicaslan I
    Ann Diagn Pathol; 2021 Oct; 54():151788. PubMed ID: 34246177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.
    Pantaleo MA; Astolfi A; Indio V; Moore R; Thiessen N; Heinrich MC; Gnocchi C; Santini D; Catena F; Formica S; Martelli PL; Casadio R; Pession A; Biasco G
    J Natl Cancer Inst; 2011 Jun; 103(12):983-7. PubMed ID: 21505157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
    Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
    PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The loss of succinate dehydrogenase B expression is frequently identified in hemangioblastoma of the central nervous system.
    Roh TH; Yim H; Roh J; Lee KB; Park SH; Jeong SY; Kim SH; Kim JH
    Sci Rep; 2019 Apr; 9(1):5873. PubMed ID: 30971719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
    Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
    Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
    Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
    Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.
    Guzy RD; Sharma B; Bell E; Chandel NS; Schumacker PT
    Mol Cell Biol; 2008 Jan; 28(2):718-31. PubMed ID: 17967865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant.
    Wurth R; Jha A; Kamilaris C; Gill AJ; Poplawski N; Xekouki P; Quezado MM; Pacak K; Stratakis CA; Hannah-Shmouni F
    Endocrinol Diabetes Metab Case Rep; 2021 Mar; 2021():. PubMed ID: 33839693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.
    Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ
    Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
    Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.